BAFF/TNFSF13B Protein, Human, Recombinant

Name: BAFF/TNFSF13B Protein, Human, Recombinant
Brand: TargetMol
SKU: TMPY-02775
Rating: 4.5 (1 reviews)

(Synonyms: ZTNF4, tumor necrosis factor (ligand) superfamily, member 13b, TNFSF20, THANK, TALL-1, TALL1, DTL, CD257, BLYS, BAFF) Copy Product Info

Synonyms: ZTNF4, tumor necrosis factor (ligand) superfamily, member 13b, TNFSF20, THANK, TALL-1, TALL1, DTL, CD257, BLYS, BAFF

Catalog No. TMPY-02775 Copy Product Info

BAFF/TNFSF13B Protein, Human, Recombinant is expressed in E. coli expression system. The predicted molecular weight is 17.2 kDa and the accession number is Q9Y275-1.

Pack Size	Price	USA Stock	Global Stock
5 µg	$87	7-10 days	7-10 days
10 µg	$142	7-10 days	7-10 days
20 µg	$233	7-10 days	7-10 days
50 µg	$462	7-10 days	7-10 days
100 µg	$716	7-10 days	7-10 days
200 µg	$1,090	7-10 days	7-10 days
500 µg	$1,950	7-10 days	7-10 days
1 mg	$3,480	7-10 days	7-10 days

For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)

Add to Cart

Add to Quotation

For research use only—not for human use. No sales to individuals. Use as intended only.

Questions

Batch Information

Select Batch

Purity:≥ 85 % as determined by SDS-PAGE

Appearance:Lyophilized powder

Color:White

Resource Download

COA User Guide of Recombinant Proteins

Product Introduction

Bioactivity

Bioactivity	Immobilized Recombinant Human BLyS/TNFSF13B/BAFF Protein (Cat#TMPY-02775) at 2 μg/mL (100 μL/well) can bind Recombinant Human TACI Protein (Fc Tag), the EC50 is 7.6-22.8 ng/mL (Routinely tested).
Description	BAFF/TNFSF13B Protein, Human, Recombinant is expressed in E. coli expression system. The predicted molecular weight is 17.2 kDa and the accession number is Q9Y275-1.
Species	Human
Expression System	E. coli
Tag	Tag Free
Accession Number	Q9Y275-1
Construction	A DNA sequence encoding the soluble form of human BAFF (Q9Y275-1) (Ala 134-Leu 285) was expressed and purified. Predicted N terminal: Met 1
Protein Purity	> 88 % as determined by SDS-PAGE
Endotoxin	Please contact us for more information.
Formulation	Lyophilized from a solution filtered through a 0.22 μm filter, containing PBS, pH 7.5. Typically, a mixture containing 5% to 8% trehalose, mannitol, and 0.01% Tween 80 is incorporated as a protective agent before lyophilization.
Reconstitution	A Certificate of Analysis (CoA) containing reconstitution instructions is included with the products. Please refer to the CoA for detailed information.
Synonyms	ZTNF4, tumor necrosis factor (ligand) superfamily, member 13b, TNFSF20, THANK, TALL-1, TALL1, DTL, CD257, BLYS, BAFF
Research Background	B lymphocyte stimulator (BLyS), also known as TNFSF13B, CD257 and BAFF, is a single-pass type II membrane protein, which belongs to the tumor necrosis factor family. BAFF is abundantly expressed in peripheral blood Leukocytes and is specifically expressed in monocytes and macrophages. BAFF is a cytokine and serves as a ligand for receptors TNFRSF13B (TACI), TNFRSF17 (BCMA), and TNFRSF13C (BAFFR). These receptors are a prominent factor in B cell differentiation, homeostasis, and selection. BLyS levels affect survival signals and selective apoptosis of autoantibody-producing B cells. Thus, it acts as a potent B cell activator and has been shown to play an important role in the proliferation and differentiation of B cells. Overexpression of BLyS in mice can lead to clinical and serological features of systemic lupus erythematosus (SLE) and Sjögren's syndrome (SS). BLyS is an attractive therapeutic target in human rheumatic diseases. The ability of BLyS to regulate both the size and repertoire of the peripheral B cell compartment raises the possibility that BLyS and antagonists thereof may form the basis of a therapeutic trichotomy. As an agonist, BLyS protein may enhance humoral immunity in congenital or acquired immunodeficiencies such as those resulting from viral infection or cancer therapy.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy

Chemical Properties

Molecular Weight

17.2 kDa (predicted); 14 kDa (reducing conditions)

Storage & Solubility Information

Shipping	In general, lyophilized powders are shipped with blue ice, while solutions are shipped with dry ice.
Storage	It is recommended to store recombinant proteins at -20°C to -80°C for future use. Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots.